In the 2018 Moshers single phase* CRACK IT Challenge £99,382 has been awarded to Rese
This award, made through our CRACK IT Challenges programme, will support the development of a more human-relevant platform for DART testing.
Researchers at the University of Dundee, working in collaboration with the University of Washington, have developed functional OCT; a non-invasive
An Edinburgh based team are archiving stem cells from patients with bipolar disorder so that they can be shared with scientists worldwide to help r
A recent publication describes a novel approach to assessing the palatability of new drugs using the amoeba Dictyostelium discoideum inste
Current immunogenicity testing of drugs considers only the ‘antigenicity’ of the drug molecule, i.e.
There are two key areas in tumour biology that must be considered when developing models to study the disease – tumour heterogeneity and the tumour
A paper reporting the development of a new automated home cage monitoring system for mice has been published this month in the journal
Dr Davide D'Amico, Chief Executive Officer of ZeClinics provides his perspective on the impact of CRACK IT Solutions on the development and app
Work funded by the NC3Rs
Stemina Biomarker Discovery, Inc. has developed two reliable human stem cell-based assays for developmental toxicity screening.